Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on December 13, 2006
J Am Soc Nephrol 18: 293-303, 2007
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2006070795

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2006070795v1
18/1/293    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kilpatrick, R. D.
Right arrow Articles by Kalantar-Zadeh, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kilpatrick, R. D.
Right arrow Articles by Kalantar-Zadeh, K.

Epidemiology and Outcomes

Association between Serum Lipids and Survival in Hemodialysis Patients and Impact of Race

Ryan D. Kilpatrick*,{dagger},{ddagger}, Charles J. McAllister§, Csaba P. Kovesdy||, Stephen F. Derose, Joel D. Kopple{dagger},{ddagger} and Kamyar Kalantar-Zadeh*,{dagger}

* Harold Simmons Center for Kidney Disease Research and Epidemiology; {dagger} Division of Nephrology and Hypertension, Los Angeles Biomedical Institute at Harbor-UCLA Medical Center, Torrance; {ddagger} School of Public Health, University of California, Los Angeles; § DaVita, Inc., El Segundo; Kaiser Permanente of Southern California, Pasadena, California; and || Division of Nephrology, Salem Veterans Affairs Medical Center, Salem, Virginia

Address correspondence to: Dr. Kamyar Kalantar-Zadeh, Division of Nephrology and Hypertension, Harbor-UCLA Medical Center, 1000 West Carson Street, Torrance, CA 90509-2910. Phone: 310-222-3891; Fax: 310-782-1837; kamkal{at}ucla.edu

Received for publication July 27, 2006. Accepted for publication October 19, 2006.

Despite the enormous cardiovascular disease epidemic among maintenance hemodialysis (MHD) patients, total hypercholesterolemia seems paradoxically to be associated with better survival. It was hypothesized that similar paradoxic associations also exist for serum LDL, HDL, and triglycerides. A 3-yr (July 2001 through June 2004) cohort of 15,859 MHD patients was studied in the United States from DaVita dialysis clinics where lipid profile was measured in at least 50% of all outpatients during a given calendar quarter. Cox proportional hazard models were adjusted for case mix and surrogates of malnutrition-inflammation complex. Both total and LDL hypercholesterolemia showed a paradoxic association with better survival. Hypertriglyceridemia (>200 mg/dl) also showed a similar trend, but serum HDL cholesterol did not have any clear association with survival. The association between a low serum LDL <70 mg/dl, which was prevalent among almost 50% of all MHD patients, and a higher all-cause death risk was robust to multivariate adjustment. In the subgroup analyses, these paradoxic associations persisted among most subgroups, although they tended to be stronger among hypoalbuminemic (<3.8 mg/dl) patients and those with a lower dietary protein intake (<1 g/kg per d). However, in black patients, a high serum LDL (>100 mg/ml) was associated with adjusted cardiovascular death hazard ratio of 1.94 (95% confidence interval 1.12 to 2.38; P = 0.02). Despite inverse associations between hyperlipidemia and survival, black MHD patients with high LDL show almost two-fold increase in cardiovascular death risk. Although these associations may not be causal, they call into question whether specific subgroups of dialysis patients are better targets for cholesterol-lowering therapy.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. Svensson, E. B. Schmidt, K. A. Jorgensen, and J. H. Christensen
The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2918 - 2924.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
K. Kalantar-Zadeh, J. D. Kopple, D. L. Regidor, J. Jing, C. S. Shinaberger, J. Aronovitz, C. J. McAllister, D. Whellan, and K. Sharma
A1C and Survival in Maintenance Hemodialysis Patients
Diabetes Care, May 1, 2007; 30(5): 1049 - 1055.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP